1242 related articles for article (PubMed ID: 3723487)
21. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
22. The effects of oral contraceptives on plasma lipids and lipoproteins.
Krauss RM
Int J Fertil; 1988; 33 Suppl():35-42. PubMed ID: 2908039
[TBL] [Abstract][Full Text] [Related]
23. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
[TBL] [Abstract][Full Text] [Related]
24. [Lipid risk factors and their role in the pathogenesis of atherosclerosis].
Vaverková H
Vnitr Lek; 1996 Mar; 42(3):191-6. PubMed ID: 8686209
[TBL] [Abstract][Full Text] [Related]
25. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
26. [The physiology of lipoprotein metabolism].
Assmann G
Infusionsther Klin Ernahr; 1983 Aug; 10(4):162-70. PubMed ID: 6618657
[TBL] [Abstract][Full Text] [Related]
27. Atherogenesis: why women live longer than men.
Hazzard WR
Geriatrics; 1985 Jan; 40(1):42-51, 54. PubMed ID: 3965355
[TBL] [Abstract][Full Text] [Related]
28. [Metabolism of atherogenic lipoproteins].
Beucler I; Turpin G
Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
[TBL] [Abstract][Full Text] [Related]
29. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
31. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
32. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women].
Somogyi A; Herold M; Kocsis I; Nagy G; Somfai G; Studinger P
Orv Hetil; 2005 Aug; 146(35):1813-8. PubMed ID: 16187540
[TBL] [Abstract][Full Text] [Related]
33. [Estrogens, progestins and blood lipids].
Tikkanen MJ
Duodecim; 1984; 100(22):1500-3. PubMed ID: 6518995
[TBL] [Abstract][Full Text] [Related]
34. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
Walsh BW; Sacks FM
J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
[TBL] [Abstract][Full Text] [Related]
35. Risks for hyperlipidemia.
Nestruck AC; Davignon J
Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
[TBL] [Abstract][Full Text] [Related]
36. Lipid modification in type 2 diabetes: the role of LDL and HDL.
Vergès B
Fundam Clin Pharmacol; 2009 Dec; 23(6):681-5. PubMed ID: 19650852
[TBL] [Abstract][Full Text] [Related]
37. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
Upton GV
Fertil Steril; 1990 Jan; 53(1):1-12. PubMed ID: 2403935
[TBL] [Abstract][Full Text] [Related]
38. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
[TBL] [Abstract][Full Text] [Related]
39. Lipid disorders in type 1 diabetes.
Vergès B
Diabetes Metab; 2009 Nov; 35(5):353-60. PubMed ID: 19733492
[TBL] [Abstract][Full Text] [Related]
40. Effects of 2,3-dihydrophthalazine-1,4-dione on Sprague Dawley rats lipid metabolism and serum lipoproteins.
Hall IH; Wong OT; Reynolds DJ; Oswald CB
Biomed Biochim Acta; 1988; 47(4-5):423-33. PubMed ID: 3240293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
